272 related articles for article (PubMed ID: 28199356)
1. Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan.
Tai SY; Chien CY; Wu DC; Lin KD; Ho BL; Chang YH; Chang YP
PLoS One; 2017; 12(2):e0171006. PubMed ID: 28199356
[TBL] [Abstract][Full Text] [Related]
2. Risk of systemic autoimmune diseases in gastric disease patients with proton pump inhibitor use: a nationwide cohort study in Taiwan.
Chen HY; Lin JJ; Yang B; Lin MC
Clin Rheumatol; 2020 Sep; 39(9):2773-2780. PubMed ID: 32152918
[TBL] [Abstract][Full Text] [Related]
3. Acid suppressants use and the risk of dementia: A population-based propensity score-matched cohort study.
Wu CL; Lei WY; Wang JS; Lin CE; Chen CL; Wen SH
PLoS One; 2020; 15(11):e0242975. PubMed ID: 33253311
[TBL] [Abstract][Full Text] [Related]
4. Cilostazol Use Is Associated with Reduced Risk of Dementia: A Nationwide Cohort Study.
Tai SY; Chien CY; Chang YH; Yang YH
Neurotherapeutics; 2017 Jul; 14(3):784-791. PubMed ID: 28194663
[TBL] [Abstract][Full Text] [Related]
5. Clinical Use of Acid Suppressants and Risk of Dementia in the Elderly: A Pharmaco-Epidemiological Cohort Study.
Chen LY; Lin HJ; Wu WT; Chen YC; Chen CL; Kao J; You SL; Chou YC; Sun CA
Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33182362
[TBL] [Abstract][Full Text] [Related]
6. Association of Proton Pump Inhibitors Usage with Risk of Pneumonia in Dementia Patients.
Ho SW; Teng YH; Yang SF; Yeh HW; Wang YH; Chou MC; Yeh CB
J Am Geriatr Soc; 2017 Jul; 65(7):1441-1447. PubMed ID: 28321840
[TBL] [Abstract][Full Text] [Related]
7. Proton Pump Inhibitors Increase the Risk of Autoimmune Diseases: A Nationwide Cohort Study.
Lin SH; Chang YS; Lin TM; Hu LF; Hou TY; Hsu HC; Shen YC; Kuo PI; Chen WS; Lin YC; Chen JH; Chang CC
Front Immunol; 2021; 12():736036. PubMed ID: 34659225
[TBL] [Abstract][Full Text] [Related]
8. Cumulative Use of Proton Pump Inhibitors and Risk of Dementia: The Atherosclerosis Risk in Communities Study.
Northuis CA; Bell EJ; Lutsey PL; George KM; Gottesman RF; Mosley TH; Whitsel EA; Lakshminarayan K
Neurology; 2023 Oct; 101(18):e1771-e1778. PubMed ID: 37558503
[TBL] [Abstract][Full Text] [Related]
9. Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from Germany.
Ahn N; Wawro N; Baumeister SE; Nolde M; Gerlach R; Tauscher M; Günter A; Güntner F; Rückert-Eheberg IM; Meisinger C; Linseisen J
Drugs Aging; 2023 Jul; 40(7):653-663. PubMed ID: 37178361
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitor use and the risk for Parkinson's disease: A nationwide population-based study in Taiwan.
Chen HL; Lei WY; Wang JH; Bair MJ; Chen CL
Medicine (Baltimore); 2023 May; 102(19):e33711. PubMed ID: 37171333
[TBL] [Abstract][Full Text] [Related]
11. Signal and Noise: Proton Pump Inhibitors and the Risk of Dementia?
Friesen KJ; Falk J; Chateau D; Kuo IF; Bugden S
Clin Pharmacol Ther; 2023 Jan; 113(1):152-159. PubMed ID: 36260313
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
Lin SM; Yang SH; Liang CC; Huang HK
Osteoporos Int; 2018 Jan; 29(1):153-162. PubMed ID: 29032384
[TBL] [Abstract][Full Text] [Related]
13. Proton Pump Inhibitor Use and Dementia Risk: Prospective Population-Based Study.
Gray SL; Walker RL; Dublin S; Yu O; Aiello Bowles EJ; Anderson ML; Crane PK; Larson EB
J Am Geriatr Soc; 2018 Feb; 66(2):247-253. PubMed ID: 29134629
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitors and dementia risk: Evidence from a cohort study using linked routinely collected national health data in Wales, UK.
Cooksey R; Kennedy J; Dennis MS; Escott-Price V; Lyons RA; Seaborne M; Brophy S
PLoS One; 2020; 15(9):e0237676. PubMed ID: 32946449
[TBL] [Abstract][Full Text] [Related]
15. Proton Pump Inhibitor Exposure and Acute Myocardial Infarction Risk: A Nested Cohort Study.
Tseng HJ; Cheng CM; Tsai SJ; Lin WC; Bai YM; Tsai CF; Su TP; Li CT; Chen TJ; Chen MH
Cardiovasc Toxicol; 2021 Jun; 21(6):444-450. PubMed ID: 33625647
[TBL] [Abstract][Full Text] [Related]
16. Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study.
Wang YF; Chen YT; Luo JC; Chen TJ; Wu JC; Wang SJ
Am J Gastroenterol; 2017 Jul; 112(7):1084-1093. PubMed ID: 28397874
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitors do not increase the risk of dementia: a systematic review and meta-analysis of prospective studies.
Desai M; Nutalapati V; Srinivasan S; Fathallah J; Dasari C; Chandrasekhar VT; Mohammad B; Kohli D; Vaezi M; Katz PO; Sharma P
Dis Esophagus; 2020 Oct; 33(10):. PubMed ID: 32476013
[TBL] [Abstract][Full Text] [Related]
18. The Uncertainty of the Association Between Proton Pump Inhibitor Use and the Risk of Dementia: Prescription Sequence Symmetry Analysis Using a Korean Healthcare Database Between 2002 and 2013.
Park SK; Baek YH; Pratt N; Kalisch Ellett L; Shin JY
Drug Saf; 2018 Jun; 41(6):615-624. PubMed ID: 29397553
[TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitors use and the risk of fatty liver disease: A nationwide cohort study.
Pyo JH; Kim TJ; Lee H; Choi SC; Cho SJ; Choi YH; Min YW; Min BH; Lee JH; Kang M; Lee YC; Kim JJ
J Gastroenterol Hepatol; 2021 May; 36(5):1235-1243. PubMed ID: 32886822
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitors and risk of periampullary cancers--A nested case-control study.
Chien LN; Huang YJ; Shao YH; Chang CJ; Chuang MT; Chiou HY; Yen Y
Int J Cancer; 2016 Mar; 138(6):1401-9. PubMed ID: 26488896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
